API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. LSE /
  3. AGY.LSE

Allergy Therapeutics (AGY LSE) stock market data APIs

p4.3 -0.23(-5.1%) as of September 19, 2024
Price chart is built with Anychart

Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Acarovac Plus, Pollinex, Synbiotics, and VLP Peanut. The company develops allergy vaccines for pollen, house dust mites, and animal fur, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Allergy Therapeutics Financial Data Overview

4.525
4.3
-
4.525
4.2
1.1048-6.3
216 M
4 766 M
53 258 K
1.398
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AGY',
Type: 'Common Stock',
Name: 'Allergy Therapeutics',
Exchange: 'LSE',
CurrencyCode: 'GBX',
CurrencyName: 'Pence sterling',
CurrencySymbol: 'p',
CountryName: 'UK',
CountryISO: 'GB',
OpenFigi: NULL,
ISIN: 'GB00B02LCQ05',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Allergy Therapeutics Fundamental Data is available in our Financial Data APIs

  • Net Revenue 53 258 K
  • EBITDA -36 998 000
  • Earnings Per Share -0.06
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Allergy Therapeutics Earnings via APIs

  • Latest Release 2024-09-25
  • EPS/Forecast NaN

Get Allergy Therapeutics End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Allergy Therapeutics latest news via APIs

Form 8.3 - The Allergy Therapeutics Plc

LONDON, June 23, 2023--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Ta...

Form 8.3 - THE ALLERGY THERAPEUTICS PLC

LONDON, June 22, 2023--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Ta...
Do you have any questions?
support@eodhistoricaldata.com